Plus Therapeutics, Inc. (CNSY) Financials
CNSY Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 14.0 million | 8.6 million |
| March 31, 2026 | 19.9 million | 8.0 million |
| Dec. 31, 2025 | 16.3 million | 12.3 million |
| Sept. 30, 2025 | 18.7 million | 13.6 million |
CNSY Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -7.6 million | 830000 |
| March 31, 2026 | -7.1 million | 1.0 million |
| Dec. 31, 2025 | -6.3 million | 713000 |
| Sept. 30, 2025 | -2.6 million | 527000 |
CNSY Net Income
No data available :(
CNSY Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 8.6 million | - | - |
| March 31, 2026 | 3.0 million | - | - |
| Dec. 31, 2025 | 8.8 million | 15000 | - |
| Sept. 30, 2025 | 16.6 million | - | 21000 |
CNSY Shares Outstanding
CNSY Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 499000 | 4.3 million | 5.2 million | - |
| March 31, 2026 | 818000 | 2.9 million | 5.3 million | - |
| Dec. 31, 2025 | 30000 | 2.9 million | 4.2 million | - |
| Sept. 30, 2025 | 27000 | 2.4 million | 3.4 million | - |
CNSY Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 411000 | 109000 |
| March 31, 2026 | 1.0 million | 109000 |
| Dec. 31, 2025 | 1.4 million | 92000 |
| Sept. 30, 2025 | 1.4 million | 86000 |
CNSY
Price: $3.07
52 week price:
Exchange: NGM
Sector: Healthcare
Industry: Medical - Pharmaceuticals
Market Capitalization: 24.0 million